Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Prothya Biosolutions logo — Prothya Biosolutions aims to be a center of excellence in pr...

Prothya Biosolutions

Prothya Biosolutions aims to be a center of excellence in protein therapies for leading pharmaceutical companies.

Founded 2021 Belgium Belgium 712 employees Private Equity Biopharma, Biotechnology +2

General Information

Company Name Prothya Biosolutions
Founded Year 2021
Location Belgium Belgium +3
Founders / Decision Makers
Team member
Employees 712
Industries Biopharma, Biotechnology, Life Sciences +1
Funding Stage Private Equity
Social

Get notified when Prothya Biosolutions moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Sep 23, 2026

Hiring for 21 positions in the last 30 days.

Get alerts when Prothya Biosolutions shows new signals

About Prothya Biosolutions

Prothya Biosolutions is a burgeoning startup in Belgium, specializing in protein therapies for major pharmaceutical companies. Established in 2021, it is the result of the integration of Plasma Industries Belgium (PIBe) and Sanquin Plasma Products (SPP), which brings together over 60 years of experience in blood plasma collection and the production of plasma-derived medicinal products. The company's expertise, inherited from its predecessors, encompasses the development of stable plasma derivatives like clotting factors, immunoglobulins, and albumin solutions. Prothya Biosolutions' commitment to leveraging the human plasma proteome's potential for revolutionizing disease diagnosis and therapeutic treatment showcases its innovative approach. The company processes approximately 3 million liters of plasma annually for various international partners, underscoring its significant production capacity. In line with its transformation into a results-oriented global organization, Prothya Biosolutions advocates for the intrinsic value of plasma-derived medicinal products for individuals and society. This approach reflects the company's revamped corporate culture epitomized by the DRIVE vision, constituting its foundational principles. Emphasizing collaboration, innovation, and the delivery of science-based solutions, Prothya Biosolutions invites individuals and potential partners to contribute to improving the health of millions of patients and participate in the forefront of Protein Therapy Development, Processing, and Manufacturing.

Taxonomy: Protein Therapies, Pharmaceutical Industry, Plasma-derived Medicinal Products, Blood Plasma Collection, Protein Therapy Development, Global Organization, Corporate Culture, Healthcare Innovation, Medical Research, Biopharmaceuticals, Disease Diagnosis, Therapeutic Treatment, Healthcare Partnerships, Medical Manufacturing, Healthcare Solutions

No funding data available for Prothya Biosolutions yet.

Get notified when Prothya Biosolutions raises funding

Prothya Biosolutions Alternatives & Competitors

Prothya Biosolutions vs
Canadian Plasma Resources
Canadian Plasma Resources

Give Plasma, Give Life

75 employees
Biotechnology, Pharmaceutical
Prothya Biosolutions vs
CAF-DCF
CAF-DCF Belgium

Life saving products in rare and often severe diseases

37 employees
Health Care, Pharmaceutical
Compare Prothya Biosolutions vs CAF-DCF
Prothya Biosolutions vs
Octapharma Plasma, Inc.
Octapharma Plasma, Inc. United States

Turn plasma into hope.

2933 employees
Biotechnology, Health Care
Compare Prothya Biosolutions vs Octapharma Plasma, Inc.
Also compare with: Prothya Biosolutions vs Biolog-id Biolog-id Prothya Biosolutions vs PlasmaGen BioSciences (P) Ltd PlasmaGen BioSciences (P) Ltd

FAQ About Prothya Biosolutions

Prothya Biosolutions aims to be a center of excellence in protein therapies for leading pharmaceutical companies.
Prothya Biosolutions was founded in 2021.
Prothya Biosolutions is headquartered in Belgium.
Prothya Biosolutions operates in the following industries: Biopharma, Biotechnology, Life Sciences, Pharmaceutical.
Prothya Biosolutions has approximately 712 employees.
Top alternatives and competitors to Prothya Biosolutions include Canadian Plasma Resources, CAF-DCF, Octapharma Plasma, Inc., Biolog-id, Plasmapp Global. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Prothya Biosolutions and Canadian Plasma Resources are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Prothya Biosolutions and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes